| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 7e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |